image
Healthcare - Biotechnology - NASDAQ - US
$ 0.22
0 %
$ 940 K
Market Cap
-0.08
P/E
CASH FLOW STATEMENT
-9.68 M OPERATING CASH FLOW
33.37%
-216 K INVESTING CASH FLOW
10.37%
3.32 M FINANCING CASH FLOW
-87.73%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Histogen Inc.
image
Net Income -10.6 M
Depreciation & Amortization 140 K
Capital Expenditures -216 K
Stock-Based Compensation 502 K
Change in Working Capital 258 K
Others 1.26 M
Free Cash Flow -9.9 M

Cash Flow

Millions
Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013
OPERATING CASH FLOW
Net Income (10.6) (15.0) (18.8) (3.0) (18.0) (17.4) (29.7) (24.1) (22.3) (15.6)
Depreciation & Amortization 0.1 97 K 98 K 0.1 91 K 0.1 0.1 67.9 K (0.5) 10.4 K
Deferred Income Tax 0 0 0.2 (0.1) 0 0 0 0 0 (54.5)
Stock Based Compensation 0.5 0.7 0.6 0.4 3.8 4.1 3.4 3.3 2.3 0.3
Other Operating Activities 61 K (0.5) 7.1 1.8 10.2 (0.9) 3.2 (2.6) 22.7 4.7
Change in Working Capital 0.3 0.1 (1.3) (0.5) (21.1) (20.6) 53.3 0.8 (20.4) 54.5
Cash From Operations (9.7) (14.5) (12.1) (1.3) (35.0) (33.2) 27.0 (22.5) (18.3) (10.6)
INVESTING CASH FLOW
Capital Expenditures (0.2) (0.2) 49 K (0.2) 66 K 25.5 K (0.1) 88.5 K (0.2) 3.91 K
Other Items 0 0 11.0 0 30.0 (39.8) 3.7 4.2 24.4 (48.4)
Cash From Investing Activities (0.2) (0.2) 11.0 (0.2) 30.0 (39.9) 3.6 4.1 24.2 (48.4)
FINANCING CASH FLOW
Common Stock Repurchased 0 0 0 0 0.5 (11.2) 0 0 0 0
Total Debt Repaid 9 K 9 K 0.5 32 K 0 11.5 0 0 0 1.0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (1.1) 6.4 0.2 0.5 0 0 0 1 (0.3) (0.5)
Cash From Financing Activities 3.3 27.1 5.8 0.5 0.5 31.1 13.6 22.4 (0.2) 59.2
CHANGE IN CASH
Net Change In Cash (6.6) 12.3 4.7 (1.0) (4.5) (42.0) 44.2 (5.9) 5.8 0.1
FREE CASH FLOW
Free Cash Flow (9.9) (14.8) (12.1) (1.4) (35.0) (33.2) 26.9 (22.6) (18.5) (10.6)